- Home
- RGNX vs IIIV Comparison
RGNX vs IIIV Comparison
Compare RGNX & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | IIIV |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 661.2M | 565.5M |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RGNX | IIIV |
|---|---|---|
| Price | $14.24 | $25.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $30.29 | ★ $33.33 |
| AVG Volume (30 Days) | ★ 626.9K | 357.7K |
| Earning Date | 11-06-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.56 |
| Revenue | $161,318,000.00 | ★ $213,158,000.00 |
| Revenue This Year | $132.80 | $8.32 |
| Revenue Next Year | $48.47 | $7.26 |
| P/E Ratio | ★ N/A | $45.71 |
| Revenue Growth | ★ 91.30 | 11.47 |
| 52 Week Low | $5.04 | $22.00 |
| 52 Week High | $14.24 | $33.97 |
Technical Indicators
Market Signals| Indicator | RGNX | IIIV |
|---|---|---|
| Relative Strength Index (RSI) | 65.99 | 45.70 |
| Support Level | $12.69 | $22.97 |
| Resistance Level | $13.42 | $25.96 |
| Average True Range (ATR) | 0.84 | 0.90 |
| MACD | 0.12 | 0.46 |
| Stochastic Oscillator | 76.90 | 76.39 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About IIIV i3 Verticals Inc.
i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.